Chromatography Media Quality Evaluation Using Lectin Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating the quality of chromatography media containing blood group A or B antigen ligands lack efficiency and reproducibility, making it challenging to ensure consistent removal of anti-A and anti-B antibodies from blood-derived products, which can lead to hemolytic reactions in recipients.
Innovation Solution
A method involving the use of purified Helix Pomatia Lectin or Griffonia simplicifolia-IsoLectin B4 to determine the static binding capacity of affinity chromatography media, allowing for comparison of media samples and assessment of their ability to remove anti-A or anti-B antibodies, thereby evaluating their quality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to evaluate chromatography media quality, then the evaluation process can be performed, but the method lacks efficiency and reproducibility
Solution Approach 1:
The patent changes the evaluation parameter from complex functional assays to simple lectin binding measurements. By using lectins that specifically bind to blood group antigens on the chromatography media, the evaluation transforms into a straightforward quantitative measurement of binding capacity, dramatically improving both reproducibility and efficiency
Solution Approach 2:
The patent introduces lectins as intermediary molecules to evaluate the chromatography media quality. These lectins serve as standardized probes that bind to the blood group antigens immobilized on the media, providing a reliable and efficient measurement of media quality without requiring complex antibody removal assays
2Reliability
If chromatography media quality is not accurately evaluated, then media can be used without extensive testing, but the ability to remove anti-A and anti-B antibodies cannot be ensured, leading to hemolytic reactions
Solution Approach 1:
The patent simplifies the quality assessment by changing from measuring antibody removal efficiency (complex) to measuring lectin binding capacity (simple). The lectin binding assay provides a direct correlate to media quality and antibody removal capability without requiring complex biological systems
Solution Approach 2:
The patent uses lectins as simplified copies or proxies for the actual antibody-antigen interaction. Instead of using complex antibodies and blood cells to assess media quality, the lectins replicate the binding function in a much simpler, more controllable system that still accurately predicts media performance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more efficient, reproducible, and reliable method for assessing the quality of chromatography media, reducing the risk of hemolytic reactions by accurately measuring the media's ability to remove antibodies, eliminating variability, and ensuring consistent performance across batches and over time.
Implementation Method 1
chromatography media containing blood group A antigen ligand or blood group B antigen ligand... bind and remove the blood group A antigen antibodies (anti-A) and blood group B antigen antibodies (anti-B)
Implementation Method 2
incubating each sample with a solution of purified Helix Pomatia (HP) Lectin or Griffonia simplicifolia-IsoLectin B4... determining the static binding capacity
Data Source
AI summary
Embodiments described herein relate to methods of evaluating quality of a chromatography media for removal of anti-A or anti-B antibodies from a sample, where the methods employ use of purified Lectins.